Neuronal differentiation of PC12 cells abolishes the expression of membrane androgen receptors

Experimental Cell Research

Volumn 312, Issue 15, 2006, Pages 2745-2756

  Alexaki, Vassilia Ismini ^a   Dermitzaki, Eirini ^a   Charalampopoulos, Ioannis ^a   Kampa, Marilena ^a   Nifli, Artemissia Phoebe ^a   Gravanis, Achille ^a   Margioris, Andrew N ^a   Castanas, Elias ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Apoptosis; Catecholamines (nor epinephrine, dopamine); Membrane binding sites (androgen); PC12 cells; Testosterone

Indexed keywords

ANDROGEN RECEPTOR; CALCIUM ION; CATECHOLAMINE; DOPAMINE; ESTROGEN RECEPTOR; NERVE GROWTH FACTOR; NORADRENALIN; TESTOSTERONE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; CALCIUM CELL LEVEL; CATECHOLAMINE RELEASE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CHROMAFFIN CELL; CONTROLLED STUDY; CYTOSOL; EPITHELIUM CELL; NERVE CELL DIFFERENTIATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ASSAY; RAT;

EID: 33747333308     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.04.023     Document Type: Article

References (72)

1. Charalampopoulos I., Tsatsanis C., Dermitzaki E., Alexaki V.I., Castanas E., Margioris A.N., and Gravanis A. Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 8209-8214
2. Alexaki V., Charalampopoulos I., Kampa M., Vassalou H., Theodoropoulos P., Stathopoulos E., Hatzoglou A., Gravanis A., and Castanas E. Estrogen exert neuroprotective effects via membrane estrogen receptors and rapid Akt/NOS activation. FASEB J. 18 (2004) 1594-1596
3. Chae H.S., Bach J.H., Lee M.W., Kim H.S., Kim Y.S., Kim K.Y., Choo K.Y., Choi S.H., Park C.H., Lee S.H., Suh Y.H., Kim S.S., and Lee W.B. Estrogen attenuates cell death induced by carboxy-terminal fragment of amyloid precursor protein in PC12 through a receptor-dependent pathway. J. Neurosci. Res. 65 (2001) 403-407
4. Wurtman R. Control of epinephrine synthesis in the adrenal medulla by the adrenal cortex: hormonal specificity and dose-response characteristics. Endocrinology 79 (1966) 608-614
5. Gelinas S., Bureau G., Valastro B., Massicotte G., Cicchetti F., Chiasson K., Gagne B., Blanchet J., and Martinoli M.G. Alpha and beta estradiol protect neuronal but not native PC12 cells from paraquat-induced oxidative stress. Neurotox. Res. 6 (2004) 141-148
6. Serova L., Rivkin M., Nakashima A., and Sabban E.L. Estradiol stimulates gene expression of norepinephrine biosynthetic enzymes in rat locus coeruleus. Neuroendocrinology 75 (2002) 193-200
7. Gollapudi L., and Oblinger M.M. Estrogen effects on neurite outgrowth and cytoskeletal gene expression in ERalpha-transfected PC12 cell lines. Exp. Neurol. 171 (2001) 308-316
8. Gollapudi L., and Oblinger M.M. Stable transfection of PC12 cells with estrogen receptor (ERalpha): protective effects of estrogen on cell survival after serum deprivation. J. Neurosci. Res. 56 (1999) 99-108
9. Charalampopoulos I., Alexaki V.I., Lazaridis I., Dermitzaki E., Avlonitis N., Tsatsanis C., Calogeropoulou T., Margioris A.N., Castanas E., and Gravanis A. G protein-associated, specific membrane binding sites mediate the neuroprotective effect of dehydroepiandrosterone. FASEB J. 20 (2006) 577-579
10. Charalampopoulos I., Dermitzaki E., Vardouli L., Tsatsanis C., Stournaras C., Margioris A.N., and Gravanis A. Dehydroepiandrosterone sulfate and allopregnanolone directly stimulate catecholamine production via induction of tyrosine hydroxylase and secretion by affecting actin polymerization. Endocrinology 146 (2005) 3309-3318
11. Kampa M., Nifli A.-P., Charalampopoulos I., Alexaki V.-I., Theodoropoulos P., Stathopoulos E., Gravanis A., and Castanas E. Opposing effects of estradiol- and testosterone-membrane binding sites on T47D breast cancer cell apoptosis. Exp. Cell Res. 307 (2005) 41-51
12. Valavanis C., Hu Y., Yang Y., Osborne B.A., Chouaib S., Greene L., Ashwell J.D., and Schwartz L.M. Model cell lines for the study of apoptosis in vitro. Methods Cell Biol. 66 (2001) 417-436
13. Rukenstein A., Rydel R.E., and Greene L.A. Multiple agents rescue PC12 cells from serum-free cell death by translation- and transcription-independent mechanisms. J. Neurosci. 11 (1991) 2552-2563
14. Connolly J.L., Greene L.A., Viscarello R.R., and Riley W.D. Rapid, sequential changes in surface morphology of PC12 pheochromocytoma cells in response to nerve growth factor. J. Cell Biol. 82 (1979) 820-827
15. Greene L.A., and Rein G. Release, storage and uptake of catecholamines by a clonal cell line of nerve growth factor (NGF) responsive pheo-chromocytoma cells. Brain Res. 129 (1977) 247-263
16. Greene L.A., and Tischler A.S. Establishment of a noradrenergic clonal line of rat pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. U. S. A. 73 (1976) 2424-2428
17. Greene L.A., and Tischler A.S. PC12 pheochromocytoma cells in neurobiological research. Adv. Cell. Neurobiol. 3 (1982) 373-414
18. Hatzoglou A., Romain S., Dalapascha H., and Castanas E. Acidification reveals a greater number of epidermal growth factor receptors in human membrane preparations. Cli. Chim. Acta 227 (1994) 97-109
19. Hatzoglou A., Kampa M., Kogia C., Charalampopoulos I., Theodoropoulos P.A., Anezinis P., Dambaki C., Papakonstanti E.A., Stathopoulos E.N., Stournaras C., Gravanis A., and Castanas E. Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo. J. Clin. Endocrinol. Metab. 90 (2005) 893-903
20. Dambaki C., Kogia C., Kampa M., Darivianaki K., Nomikos M., Anezinis P., Theodoropoulos P.A., Castanas E., and Stathopoulos E.N. Membrane testosterone binding sites in prostate carcinoma as a potential new marker and therapeutic target: study in paraffin tissue sections. BMC Cancer 5 (2005) 148
21. 2+ indicators excited with visible light. Cell Calcium 39 (2006) 3-11
22. Johnson J.D., Ahmed N.T., Luciani D.S., Han Z., Tran H., Fujita J., Misler S., Edlund H., and Polonsky K.S. Increased islet apoptosis in Pdx1+/- mice. J. Clin. Invest. 111 (2003) 1147-1160
23. Wassell J., Reed P., Kane J., and Weinkove C. Freedom from drug interference in new immunoassays for urinary catecholamines and metanephrines. Clin. Chem. 45 (1999) 2216-2223
24. Kampa M., Papakonstanti E.A., Hatzoglou A., Stathopoulos E.N., Stournaras C., and Castanas E. The human prostate cancer cell line LNCaP bears functional membrane testosterone receptors that increase PSA secretion and modify actin cytoskeleton. FASEB J. 16 (2002) 1429-1431
25. Lieberherr M., and Grosse B. Androgens increase intracellular calcium concentration and inositol 1,4,5-triphosphate and diacylglycerol formation via a pertussis toxin sensitive G-protein. J. Biol. Chem. 269 (1994) 7217-7223
26. Losel R., and Wehling M. Nongenomic actions of steroid hormones. Nat. Rev., Mol. Cell Biol. 4 (2003) 46-56
27. Kampa M., Papakonstanti E.A., Alexaki V.I., Hatzoglou A., Stournaras C., and Castanas E. The opioid agonist ethylketocyclazocine reverts the rapid, non-genomic effects of membrane testosterone receptors in the human prostate LNCaP cell line. Exp. Cell Res. 294 (2004) 434-445
28. Benten W.P., Lieberherr M., Giese G., Wrehlke C., Stamm O., Sekeris C.E., Mossmann H., and Wunderlich F. Functional testosterone receptors in plasma membranes of T cells. FASEB J. 13 (1999) 123-133
29. Benten W.P., Guo Z., Krucken J., and Wunderlich F. Rapid effects of androgens in macrophages. Steroids 69 (2004) 585-590
30. Sattayaprasert P., Choi H.B., Chongthammakun S., and McLarnon J.G. Platelet-activating factor enhancement of calcium influx and interleukin-6 expression, but not production, in human microglia. J. Neuroinflammation 2 (2005) 11
31. Khoo C., Helm J., Choi H.B., Kim S.U., and McLarnon J.G. Inhibition of store-operated Ca(2+) influx by acidic extracellular pH in cultured human microglia. Glia 36 (2001) 22-30
32. Nifli A.P., Bosson-Kouame A., Papadopoulou N., Kogia C., Kampa M., Castagnino C., Stournaras C., Vercauteren J., and Castanas E. Monomeric and oligomeric flavanols are agonists of membrane androgen receptors. Exp. Cell Res. 309 (2005) 329-339
33. Gelinas S., and Martinoli M.G. Neuroprotective effect of estradiol and phytoestrogens on MPP+-induced cytotoxicity in neuronal PC12 cells. J. Neurosci. Res. 70 (2002) 90-96
34. Mattson M.P., Robinson N., and Guo Q. Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1. NeuroReport 8 (1997) 3817-3821
35. Papakonstanti E.A., Kampa M., Castanas E., and Stournaras C. A rapid, nongenomic, signaling pathway regulates the actin reorganization induced by activation of membrane testosterone receptors. Mol. Endocrinol. 17 (2003) 870-881
36. Green P.S., Bishop J., and Simpkins J.W. 17 alpha-estradiol exerts neuroprotective effects on SK-N-SH cells. J. Neurosci. 17 (1997) 511-515
37. Nilsen J., and Brinton R.D. Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology 143 (2002) 205-212
38. Gonzalez Deniselle M.C., Lopez Costa J.J., Gonzalez S.L., Labombarda F., Garay L., Guennoun R., Schumacher M., and De Nicola A.F. Basis of progesterone protection in spinal cord neurodegeneration. J. Steroid Biochem. Mol. Biol. 83 (2002) 199-209
39. Baizer L., and Weiner N. Nerve growth factor treatment enhances nicotine-stimulated dopamine release and increases in cyclic adenosine 3′:5′-monophosphate levels in PC12 cell cultures. J. Neurosci. 5 (1985) 1176-1179
40. Ikeda T., Kitayama S., Morita K., and Dohi T. Nerve growth factor down-regulates the expression of norepinephrine transporter in rat pheochromocytoma (PC12) cells. Brain Res. Mol. Brain Res. 86 (2001) 90-100
41. Qiu J., Wang P., Jing Q., Zhang W., Li X., Zhong Y., Sun G., Pei G., and Chen Y. Rapid activation of ERK1/2 mitogen-activated protein kinase by corticosterone in PC12 cells. Biochem. Biophys. Res. Commun. 287 (2001) 1017-1024
42. MacLusky N., Chalmers-Redman R., Kay G., Ju W., IS N., and Tatton W. Ovarian steroids reduce apoptosis induced by trophic insufficiency in nerve growth factor-differentiated pc12 cells and axotomized rat facial motoneurons. Neuroscience 118 (2003) 741-754
43. Alexaki V.I., Charalampopoulos I., Kampa M., Nifli A.P., Hatzoglou A., Gravanis A., and Castanas E. Activation of membrane estrogen receptors induce pro-survival kinases. J. Steroid Biochem. Mol. Biol. 98 (2006) 97-110
44. Yao R., and Cooper G. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267 (1995) 2003-2006
45. Vyas S., Juin P., Hancock D., Suzuki Y., Takahashi R., Triller A., and Evan G. Differentiation-dependent sensitivity to apoptogenic factors in PC12 cells. J. Biol. Chem. 279 (2004) 30983-30993
46. Kelly M., and Levin E. Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol. Metab. 12 (2001) 152-156
47. Funder J. The nongenomic actions of aldosterone. Endocr. Rev. 26 (2005) 313-321
48. Zhu Y., Rice C.D., Pang Y., Pace M., and Thomas P. Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 2231-2236
49. Filardo E.J., and Thomas P. GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol. Metab. 16 (2005) 362-367
50. Thomas P., Pang Y., Filardo E.J., and Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146 (2005) 624-632
51. 2+ kinetics in rat coronary endothelial cells are exerted via aromatization to estrogens. Am. J. Physiol.: Heart Circ. Physiol. 287 (2004) H63-H71
52. Tsai C.H., Su S.F., Chou T.F., and Lee T.M. Differential effects of sarcolemmal and mitochondrial K(ATP) channels activated by 17 beta-estradiol on reperfusion arrhythmias and infarct sizes in canine hearts. J. Pharmacol. Exp. Ther. 301 (2002) 234-240
53. Doolan C.M., Condliffe S.B., and Harvey B.J. Rapid non-genomic activation of cytosolic cyclic AMP-dependent protein kinase activity and [Ca(2+)](i) by 17beta-oestradiol in female rat distal colon. Br. J. Pharmacol. 129 (2000) 1375-1386
54. Fiorelli G., Gori F., Frediani U., Franceschelli F., Tanini A., Tosti-Guerra C., Benvenuti S., Gennari L., Becherini L., and Brandi M.L. Membrane binding sites and non-genomic effects of estrogen in cultured human pre-osteoclastic cells. J. Steroid Biochem. Mol. Biol. 59 (1996) 233-240
55. Driggers P.H., and Segars J.H. Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling. Trends Endocrinol. Metab. 13 (2002) 422-427
56. Filardo E., Quin J., Bland K., and Frackelton A.R. Estrogen induced activation of Erk-1 and Erk-2 requires the G protein coupled receptor homolog, GPR30, and occurs via transactivation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol. 14 (2000) 1649-1660
57. Chen Y.Z., and Qiu J. Pleiotropic signaling pathways in rapid, nongenomic action of glucocorticoid. Mol. Cell. Biol. Res. Commun. 2 (1999) 145-149
58. Liu D., and Dillon J.S. Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3). J. Biol. Chem. 277 (2002) 21379-21388
59. Walker W.H. Nongenomic actions of androgen in Sertoli cells. Curr. Top. Dev. Biol. 56 (2003) 25-53
60. Stathopoulos E.N., Dambaki C., Kampa M., Theodoropoulos P.A., Anezinis P., Delakas D., Delides G.S., and Castanas E. Membrane androgen binding sites are preferentially expressed in human prostate carcinoma cells. BMC Clin. Pathol. 3 (2003) 1
61. Guo Z., Benten W.P., Krucken J., and Wunderlich F. Nongenomic testosterone calcium signaling. Genotropic actions in androgen receptor-free macrophages. J. Biol. Chem. 277 (2002) 29600-29607
62. 2+ influx via non-genomic surface receptors in activated T cells. FEBS Lett. 407 (1997) 211-214
63. Shafer T.J., and Atchison W.D. Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: a model for neurotoxicological studies. Neurotoxicology 12 (1991) 473-492
64. Bright G.R., Agani F.H., Haque U., Overholt J.L., and Prabhakar N.R. Heterogeneity in cytosolic calcium responses to hypoxia in carotid body cells. Brain Res. 706 (1996) 297-302
65. Hatzoglou A., Kampa M., and Castanas E. Opioid-somatostatin interactions in regulating cancer cell growth. Front. Biosci. 10 (2005) 244-256
66. Giraud P., Eiden L., Castanas E., Conte-Devolx B., Boudouresque F., Jaquet P., and Oliver C. Opiate peptides of the adrenal medulla (author's transl). Nouv. Presse Med. 11 (1982) 1867-1871
67. Dermitzaki E., Gravanis A., Venihaki M., Stournaras C., and Margioris A.N. Opioids suppress basal and nicotine-induced catecholamine secretion via a stabilizing effect on actin filaments. Endocrinology 142 (2001) 2022-2031
68. Venihaki M., Gravanis A., and Margioris A.N. Opioids inhibit dopamine secretion from PC12 rat pheochromocytoma cells in a naloxone-reversible manner. Life Sci. 58 (1996) 75-82
69. Banerjee A., Martin T.F., and DasGupta B.R. Nerve growth factor induces sensitivity to botulinum neurotoxin type A in norepinephrine-secreting PC12 cells. Neurosci. Lett. 164 (1993) 93-96
70. Gross J., Leclere N., Heldt J., Muller I., Kietzmann T., and Andreeva N. Differential effects of hypoxia on untreated and NGF treated PC12 cells. Life Sci. 67 (2000) 2595-2603
71. Rudkin B.B., Lazarovici P., Levi B.Z., Abe Y., Fujita K., and Guroff G. Cell cycle-specific action of nerve growth factor in PC12 cells: differentiation without proliferation. EMBO J. 8 (1989) 3319-3325
72. Compagnone N., and Mellon S. Neurosteroids: biosynthesis and function of these novel neuromodulators. Fron. Neuroendocrinol. 21 (2000) 1-56